Home Ideas & Research Indexes Hedge Funds Portfolios My tickerspy Newswire
Enter ticker(s) QQQ: 73.41 -0.05%   SPY: 165.31 -0.09%
Profile Portfolio Notes & Links Tracked By  


  Track this member and follow their portfolio moves with tickerspy™ alerts  

cooper


Portfolio List (2):
drugs delivery



  Performance       Ideas       Community  
 
Today:
Week:
1-month:
All-time:
+2.6%
+1.1%
-1.4%
+146.2%
vs S&P 500:
vs S&P 500:
vs S&P 500:
vs S&P 500:
+2.7%
+2.0%
-5.7%
+67.0%
     
Similar Portfolios also own:
ELN, KEY, INSV, [CEPH], CLSN, ACUR, JNJ, DCTH, BAC, LLY
 

     
Share this portfolio on Facebook
Share this portfolio on Twitter
 
                     
     
 
Chart View
1 week
 
1 month
 
3 months
 
6 months
 
All Time
 
 
 

 
 
 
 
   
     
 
Portfolio Detail
 
  Standard View     Performance View     Portfolio HistoryNEW    
Click a column to sort | Scroll over columns for more information
 
 Ticker Last Trade Today's Change Volume  % of
Daily
Mkt Cap  Div Yield  % off
52wk lw
% from
52wk hg
Gain View as: Alerts Comments
 ALKS $32.84 -0.16 -0.5% 2,174,934 125% $4.3B - 122% -1% +281.4%
 CBRX $0.62 0.00 -0.2% 182,357 59% $54.1M - 12% -50% -51.3%
 DRRX $0.85 -0.04 -4.2% 105,769 12% $86.9M - 40% -54% -63.5%
 FLML $4.66 +0.04 +0.9% 38,138 74% $116.3M - 64% -17% -25.0%
 HSP $35.08 -0.10 -0.3% 518,587 39% $5.8B - 23% -7% +2.2%
 KVPHQ $0.10 0.00 +4.6% 121,142 103% $6.2M - 304% -93% -93.8%
 NKTR $9.27 -0.04 -0.4% 929,055 88% $1.0B - 64% -18% +43.1%
 [NOVN] $0.00 0.00 0.0% 0% $ - N/A% N/A% -100.0%
 [PPCO] $0.00 0.00 0.0% 0% $ - N/A% N/A% -100.0%
 VRX $84.47 +9.80 +13.1% 10,383,614 839% $25.6B - 99% 7% +610.4%
Close [X]  
Post a comment on this stock.
(250 character limit)

Make comment private

Delete Comment

Close [X]  
Post a comment on this stock.
(250 character limit)

Make comment private

Delete Comment

Close [X]  
Post a comment on this stock.
(250 character limit)

Make comment private

Delete Comment

Close [X]  
Post a comment on this stock.
(250 character limit)

Make comment private

Delete Comment

Close [X]  
Post a comment on this stock.
(250 character limit)

Make comment private

Delete Comment

Close [X]  
Post a comment on this stock.
(250 character limit)

Make comment private

Delete Comment

Close [X]  
Post a comment on this stock.
(250 character limit)

Make comment private

Delete Comment

Close [X]  
Post a comment on this stock.
(250 character limit)

Make comment private

Delete Comment

Close [X]  
Post a comment on this stock.
(250 character limit)

Make comment private

Delete Comment

Close [X]  
Post a comment on this stock.
(250 character limit)

Make comment private

Delete Comment

Discuss this portfolio with cooper
 
Latest Portfolio Notes & Links
 
View: Headlines   |   Message Board   |   Portfolio Notes  
 
 
Warburg Would Reap Threefold Return in Bausch Transaction
ACT  VRX  
Linked by Bloomberg ( track newsfeed | ignore newsfeed ) - May 24, 06:43PM from (www.bloomberg.com)
Warburg Pincus LLC would reap more than a threefold return on its $1.7 billion equity investment in Bausch & Lomb  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Bausch & Lomb Unit Pays $33.5 Million in Misbranding Case
VRX  
Linked by Bloomberg ( track newsfeed | ignore newsfeed ) - May 24, 05:28PM from (www.bloomberg.com)
Ista Pharmaceuticals Inc., a unit of Bausch & Lomb Inc. that makes medicine to treat eye ailments, agreed to pay  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
DealBook: Bausch & Lomb Said to Be Near $9 Billion Sale to Valeant
VRX  
Linked by NYTimes ( track newsfeed | ignore newsfeed ) - May 24, 12:56PM from (dealbook.nytimes.com)
If completed, a transaction would be one of the biggest health care deals of the year. And it could reap a sizable profit  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Wockhardt Drug Filings Seen Delayed After U.S. FDA Alert
HSP  
Linked by Bloomberg ( track newsfeed | ignore newsfeed ) - May 24, 08:33AM from (www.bloomberg.com)
Wockhardt Ltd. (WPL), an Indian maker of insulin and hepatitis vaccines, will not win new drug approvals this year for about  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Alkermes plc Reports Financial Results for Fiscal Year 2013 and Provides Financial Expectations
ALKS  
Linked by BusinessWire ( track newsfeed | ignore newsfeed ) - May 23, 07:00AM from (www.businesswire.com)
Alkermes plc (NASDAQ: ALKS) today reported financial results for its fourth quarter and fiscal year ended March 31, 2013.  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
A Good Deal For Actavis, But Warner Chilcott Goes A Little Cheap
MYL  ACT  VRX  WCRX  
Linked by Investopedia Stock Analysis ( track newsfeed | ignore newsfeed ) - May 21, 02:00PM from (www.investopedia.com)
Actavis gets a very useful asset, while Warner Chilcott shareholders get a decent exit.  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Pharma M&A – Actavis to Acquire Warner Chilcott
FRX  MYL  TEVA  ACT  VRX  WCRX  
Linked by Benzinga.com ( track newsfeed | ignore newsfeed ) - May 20, 11:32AM from (www.benzinga.com)
On Monday, generic drug maker Actavis Inc. (NYSE: ACT) announced plans to purchase specialty pharmaceutical company Warner  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
DealBook: Actavis to Buy Warner Chilcott in All-Stock Deal
MYL  VRX  WCRX  
Linked by NYTimes ( track newsfeed | ignore newsfeed ) - May 20, 08:16AM from (dealbook.nytimes.com)
Actavis, a maker of generic drugs, agreed to buy the specialty pharmaceutical company Warner Chilcott for about $5 billion  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
'Love Hormone' Promises Safer Births After Pfizer Flop
PFE  MNKD  NKTR  
Linked by Bloomberg ( track newsfeed | ignore newsfeed ) - May 19, 06:03PM from (www.bloomberg.com)
A hormone treatment based on technology used in Pfizer Inc. (PFE)’s failed inhalable insulin shows promise in fighting the leading cause of maternal mortality.
 more ...

Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Alkermes to Host Conference Call to Discuss Financial Results for Fiscal Year 2013
ALKS  
Linked by BusinessWire ( track newsfeed | ignore newsfeed ) - May 16, 04:00PM from (www.businesswire.com)
Alkermes plc (NASDAQ: ALKS) will host a conference call at 8:00 a.m. EDT (1:00 p.m. BST) on Thursday, May 23, 2013, to discuss  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Alkermes Elects Nancy Wysenski to Board of Directors
ALKS  
Linked by BusinessWire ( track newsfeed | ignore newsfeed ) - May 16, 07:00AM from (www.businesswire.com)
Alkermes plc (NASDAQ: ALKS) today announced the election of Nancy J. Wysenski to the company’s Board of Directors. Most  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Summary of Jana Partners 13F: Aetna, Expedia and Kinder Morgan All Raised Among Others
AIG  BA  KO  SVU  FNP  BIG  ODP  WM  BMC  SYMC  IACI  CPRT  TK  AGU  OPK  VRSN  IRM  CVG  AXL  NFLX  VC  AET  HSP  ASH  ROC  EXPE  LYV  SE  KAR  DTV  LINTA  QEP  SEMG  KMI  GRPN  ZNGA  TRIP  ADT  FANG  LMCA  
Linked by Benzinga.com ( track newsfeed | ignore newsfeed ) - May 15, 03:24PM from (www.benzinga.com)
Barry Rosenstein's JANA Partners released its 13F for Q1 Wednesday.  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
What We're Reading ~ Analytical Links 5/15/13
VZ  VOD  DLTR  HSP  FLT  
Linked by market folly ( track newsfeed | ignore newsfeed ) - May 15, 01:05PM from (www.marketfolly.com)
Meb Faber's new book: Shareholder Yield [Meb Faber]



Explanation of Tepper's chart: Equity risk premium is high (this is bullish) [The Big Picture]
 more ...

Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Michael Price's Presentation at London Value Conference: Long Hospira & Hess
HES  HSP  BRK.A  
Linked by market folly ( track newsfeed | ignore newsfeed ) - May 13, 01:52PM from (www.marketfolly.com)
Continuing our notes from the London Value Investor Conference 2013, the next speaker is Michael Price of MFP Investors.   more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
The Week Ahead: Full Slate of Economic Data; Earnings From Cisco, Wal-Mart and Deere
SSI  BWS  JWN  WMT  DE  ACAT  ADSK  M  PLAB  CSCO  ALKS  KSS  SSYS  TTWO  BRCD  SKX  A  SINA  NTES  JCP  ARUN  IOC  
Linked by Benzinga.com ( track newsfeed | ignore newsfeed ) - May 10, 09:59PM from (www.benzinga.com)
A host of economic data is set to be released for the week beginning May 13. Investors will also continue to be focused on  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Mid-Morning Market Update: Gold Futures See Sharp Decline, Ubiquity Networks Reports Growth for Second Straight Quarter
PFE  PTIE  DRRX  IFMI  TSLA  MCP  
Linked by Benzinga.com ( track newsfeed | ignore newsfeed ) - May 10, 10:47AM from (www.benzinga.com)
Following the market opening Friday, the Dow traded up 0.13 percent to 15,102.64, while the NASDAQ gained 0.42 percent to  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Adasuve Deal Is Very Good For Alexza, But What About Teva?
BMY  LLY  TEVA  VRX  ALXA  
Linked by Investopedia Stock Analysis ( track newsfeed | ignore newsfeed ) - May 09, 04:45PM from (www.investopedia.com)
Teva's partnership with Alexza looks like an expensive gamble.  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Nektar Therapeutics Reports Financial Results for the First Quarter of 2013
NKTR  
Posted by PR Newswire ( track newsfeed | ignore newsfeed ) - May 09, 04:15PM

SAN FRANCISCO, May 9, 2013 /PRNewswire/ -- Nektar Therapeutics  more ...
Flag Post a comment

Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Hospira Sues B. Braun Over Infusion-Pump System Patents
HSP  
Linked by Bloomberg ( track newsfeed | ignore newsfeed ) - May 09, 11:09AM from (www.bloomberg.com)
Hospira Inc. (HSP), a maker of acute-care products, sued a U.S. unit of Germany’s B. Braun Melsungen AG alleging infringement of patents for drug-infusion pump technology.
 more ...

Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
ICU Said to Explore Sale That May Fetch $1 Billion
JPM  ICUI  HSP  
Linked by Bloomberg ( track newsfeed | ignore newsfeed ) - May 08, 01:10PM from (www.bloomberg.com)
ICU Medical Inc. (ICUI), the San Clemente, California-based producer of intravenous medical equipment, is weighing a sale  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Page 1 2 3 4 5 6 7 8 9 ... 34



Close [X]  
Post a description about this portfolio.
(150 character limit)

Click to close X

Use portfolios to track tickers you're interested in. News related to your tickers will appear below the portfolio. Tickers in your portfolios will generate Alerts on your tickerspy Alerts page.

The Recent Tickers portfolio saves the tickers you've recently viewed on the site.

Click to close X

By matching similar portfolios, tickerspy helps members find institutional and individual investors with strategies similar to their own.

Click to close X

Portfolio performance for tickerspy member portfolios is calculated by equally weighting all of the stocks held in the portfolio.

Click to close X

Performance View offers a snapshot of how individual portfolio positions have performed since being added (or shorted) as well as a look at the individual stocks' performance over various time periods. In the case of "shorts," a decline in price will result in a positive gain.

Portfolio History offers a view of all current and past holdings in a portfolio.

Click to close X

Institutional Holdings Disclaimer

Pro portfolios track the top 15 quarterly holdings of more than 1,400 institutions. Comments in Pro portfolios show the institution's change in shares held for each company quarter over quarter.

Pro portfolio performance is based on institutions' top 15 holdings as disclosed in quarter-end filings with the SEC. Pro performance does not take into account additional holdings beyond the top 15 nor does it include positions that are not required to be disclosed by the SEC. As such, Pro portfolio performance should be considered an approximation and not a precise record of how an institution has performed over time.

tickerspy is not affiliated with any of the Pro investors profiled on our web site. The performance data and graph are estimates and do not represent an advertisement or endorsement by either tickerspy or the Pro investors.

Click to close X

To calculate "all-time" Pro performance, we combine all of the quarterly holdings reports for that Pro investor. The initial date used is the start date of the first quarterly holdings report we have in our database. Start dates vary based on the first quarterly holdings report we have for each Pro. Please see our Institutional Holdings Disclaimer (located at the bottom of this page) for more on how we calculate Pro portfolio performance estimates. tickerspy is not affiliated with any of Pro investors profiled on our web site.

Click to close X

Your primary portfolio will appear in other member’s Tracking Hubs when they track your performance. Your primary portfolio is also used in our Ideas & Research section, where your portfolio is compared with the portfolios of other members, and elsewhere on the site where other portfolio comparisons are made.

Note: Primary portfolios must contain at least five stocks of greater than $1 per share. If you have elected to make your primary portfolio private or if your portfolio is not eligible to be primary, it will not appear in the Ideas & Research section or on the front page.

Click to close X

Primary portfolio

Click to close X
Click the Alerts links in your portfolio to see news from the last 36 hours as well as data alerts displaying unusual price and volume action. You will also see Alerts related to the activity of other tickerspy members. To see more Alerts, visit your customized Alerts page. And for more Alerts info, visit our Alerts FAQ.
Click to close X
The Recent Tickers portfolio saves the tickers you've recently viewed on the site.